New search | Conferencedetail
Print view
 
 

3rd Treg Directed Therapies Summit

Evvnt Promotion / evvnt
-
18.05.2021 - 20.05.2021  Online
Time: 09:00 - 17:30
 
Conference themes
Running digitally for 2021, the 3rd Treg Directed Therapies Summit is the industry-led meeting focused on targeting and translating Treg modifying therapies with enhanced persistence and durability safely and at scale.

Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, to discuss how to robustly modify the Treg response.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Adel Nada, CEO, GentiBio, Jeremie Mariau, CEO, ILTOO PHARMA, Jo Viney, Co-Founder, President and CSO, Pandion Therapeutics, Marc Martinez- Llordella, co-Founder and VP Biology, Quell Therapeutics and more.
 

Enquiries and Registration:

https://go.evvnt.com/710471-1?pid=4832
Mr. Treg Directed Therapies Summit Team
 
Categories
General Medicine
Languages
English
Congress fees
Drug Developers (Earlybird rates and workshops available): USD 2099.0, Academic (Earlybird rates and workshops available): USD 1899.0, Service Providers (Earlybird rates and workshops available): USD 2599.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAlumni Club Medizinische Universität WienAMREF - African Medical and Research FoundationÖsterreichisches Rotes KreuzEuropean Health Forum GasteinHelix - Forschung & Beratung WienHilfswerk Austria